Published in Cell Transplant on January 01, 2004
Clinical imaging in regenerative medicine. Nat Biotechnol (2014) 1.43
Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke (2010) 1.37
In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One (2009) 1.12
Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther (2011) 1.04
Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound. Stem Cells (2012) 1.00
Concentration-dependent rheological properties of ECM hydrogel for intracerebral delivery to a stroke cavity. Acta Biomater (2015) 0.88
Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications. J Transl Med (2012) 0.83
Radially branched deployment for more efficient cell transplantation at the scale of the human brain. Stereotact Funct Neurosurg (2013) 0.81
The effect of injection using narrow-bore needles on mammalian cells: administration and formulation considerations for cell therapies. J Pharm Pharmacol (2015) 0.77
A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow-Bore Needles. Stem Cells Transl Med (2016) 0.76
Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deployment. Mol Ther (2014) 0.75
Korean stem-cell researchers focus on the clinic. Nat Rep Stem Cells (2007) 0.75
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Arteriovenous malformations. Lancet (2002) 3.15
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg (2005) 2.87
Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci (2005) 2.53
Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab (2006) 2.41
Cell transplantation therapy for stroke. Stroke (2007) 2.30
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol (2006) 2.17
Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery (2012) 2.06
Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A (2007) 2.03
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus (2008) 1.84
Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci (2004) 1.71
Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem (2003) 1.69
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab (2008) 1.59
Multimodality treatment of posterior fossa arteriovenous malformations. J Neurosurg (2008) 1.59
General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb Blood Flow Metab (2007) 1.57
The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem (2008) 1.54
Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke (2005) 1.54
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Spinal pilocytic astrocytoma in an elderly patient. World Neurosurg (2011) 1.49
Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke (2010) 1.44
Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis (2006) 1.40
Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One (2008) 1.37
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology (2014) 1.36
Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab (2004) 1.36
Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg (2009) 1.35
Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke (2011) 1.34
Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther (2009) 1.34
Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum Mol Genet (2002) 1.33
Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A (2011) 1.32
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Aneurysmal subarachnoid hemorrhage in patients with Hunt and Hess grade 4 or 5: treatment using the Guglielmi detachable coil system. AJNR Am J Neuroradiol (2003) 1.27
Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol (2002) 1.26
Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab (2002) 1.21
Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol (2005) 1.20
Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev (2009) 1.18
Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab (2007) 1.17
Paradoxical cerebral herniation secondary to lumbar puncture after decompressive craniectomy for a large space-occupying hemispheric stroke: case report. Neurosurgery (2005) 1.16
Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods (2011) 1.16
New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Curr Neurovasc Res (2006) 1.14
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann Neurol (2002) 1.12
Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J Cereb Blood Flow Metab (2005) 1.12
DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res (2007) 1.11
Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus (2009) 1.10
Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery (2003) 1.10
Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg (2003) 1.08
Intravascular cell replacement therapy for stroke. Neurosurg Focus (2008) 1.07
Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 1.06
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol (2013) 1.05
Surgical and endovascular management of symptomatic posterior circulation fusiform aneurysms. J Neurosurg (2007) 1.05
The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke (2011) 1.05
Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol (2004) 1.04
Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery (2008) 1.04
Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther (2011) 1.04
epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett (2008) 1.04
Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus (2009) 1.04
Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery (2012) 1.03
Cavernous malformation of brainstem, thalamus, and basal ganglia: a series of 176 patients. Neurosurgery (2013) 1.03
Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion. J Neurosurg (2007) 1.03
Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One (2012) 1.02
Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia. Neurobiol Dis (2002) 1.02
Neurosurgical advances in the treatment of moyamoya disease. Stroke (2011) 1.02
Assessment of outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 60 years of age. Neurosurg Focus (2009) 1.01
Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J Cereb Blood Flow Metab (2008) 1.00
Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet (2011) 0.99
Positron emission tomography imaging of poststroke angiogenesis. Stroke (2008) 0.99
Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke (2012) 0.99
The use of human mesenchymal stem cell-derived feeder cells for the cultivation of transplantable epithelial sheets. Invest Ophthalmol Vis Sci (2009) 0.99
Patients with moyamoya disease presenting with movement disorder. J Neurosurg Pediatr (2010) 0.99
FasL shedding is reduced by hypothermia in experimental stroke. J Neurochem (2008) 0.99
Functional engraftment of the medial ganglionic eminence cells in experimental stroke model. Cell Transplant (2009) 0.98
Epsilon PKC may contribute to the protective effect of hypothermia in a rat focal cerebral ischemia model. Stroke (2007) 0.98
Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia. Cell Transplant (2010) 0.98
Potential of adult neural stem cells in stroke therapy. Regen Med (2008) 0.98
Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One (2013) 0.98
Mild postischemic hypothermia prolongs the time window for gene therapy by inhibiting cytochrome C release. Stroke (2004) 0.97
Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus (2009) 0.97
Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. J Stroke Cerebrovasc Dis (2010) 0.96
Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J Cereb Blood Flow Metab (2002) 0.96
Hypothermia blocks beta-catenin degradation after focal ischemia in rats. Brain Res (2008) 0.96
Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth. J Neurosci Res (2009) 0.94
Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant (2013) 0.94
Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Pituitary (2009) 0.92
Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: is treatment justified? Stroke (2006) 0.91
Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol (2013) 0.91
Revascularization of the posterior circulation. Skull Base (2005) 0.91
Progressive cerebral vascular degeneration with mitochondrial encephalopathy. Am J Med Genet A (2008) 0.91
Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype. Am J Med Genet A (2010) 0.91
Management of pediatric intracranial arteriovenous malformations: experience with multimodality therapy. Neurosurgery (2011) 0.91
Predictors of clinical and angiographic outcome after surgical or endovascular therapy of very large and giant intracranial aneurysms. Neurosurgery (2011) 0.90
Morphologic assessment of middle cerebral artery aneurysms for endovascular treatment. J Stroke Cerebrovasc Dis (2007) 0.90
Gene expression profiling of blood in brain arteriovenous malformation patients. Transl Stroke Res (2011) 0.90
Prokineticin 2 is an endangering mediator of cerebral ischemic injury. Proc Natl Acad Sci U S A (2012) 0.90
Surgical management of posterior fossa arteriovenous malformations. Neurosurgery (2006) 0.89
The protective effect of early hypothermia on PTEN phosphorylation correlates with free radical inhibition in rat stroke. J Cereb Blood Flow Metab (2009) 0.89
Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course. Neurosurg Focus (2009) 0.89